Male Hormonal Contraceptive Development-ACY-5
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Male Hormonal Contraceptive Development-ACY-5 is a clinical trial[1].
Key Facts
- Male Hormonal Contraceptive Development-ACY-5 is in the country of United States[2].
- Male Hormonal Contraceptive Development-ACY-5's instance of is recorded as clinical trial[3].
- Male Hormonal Contraceptive Development-ACY-5's start time is recorded as +2004-05-31T00:00:00Z[4].
- Male Hormonal Contraceptive Development-ACY-5's end time is recorded as +2006-04-30T00:00:00Z[5].
- Male Hormonal Contraceptive Development-ACY-5's sponsor is recorded as University of Washington[6].
- Male Hormonal Contraceptive Development-ACY-5's number of participants is recorded as {'unit': '1', 'amount': '+43'}[7].
- Male Hormonal Contraceptive Development-ACY-5's title is recorded as Male Hormonal Contraceptive Development: Suppression of Spermatogenesis With the Addition of a Potent Antagonist (Acyline) to Testosterone and DMPA (ACY-5)[8].
- Male Hormonal Contraceptive Development-ACY-5's short name is recorded as ACY-5[9].
- Male Hormonal Contraceptive Development-ACY-5's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Male Hormonal Contraceptive Development-ACY-5's ClinicalTrials.gov ID is recorded as NCT00161447[11].
- Male Hormonal Contraceptive Development-ACY-5's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[12].
- Male Hormonal Contraceptive Development-ACY-5's research intervention is recorded as postcoital contraceptives[13].
- Male Hormonal Contraceptive Development-ACY-5's research intervention is recorded as medroxyprogesterone[14].
- Male Hormonal Contraceptive Development-ACY-5's research intervention is recorded as acyline[15].
- Male Hormonal Contraceptive Development-ACY-5's clinical trial phase is recorded as phase I clinical trial[16].
- Male Hormonal Contraceptive Development-ACY-5's clinical trial phase is recorded as phase II clinical trial[17].
- Male Hormonal Contraceptive Development-ACY-5's research site is recorded as University of Washington[18].
- Male Hormonal Contraceptive Development-ACY-5's study type is recorded as interventional study[19].